HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma.

Abstract
A prospective clinical study to assess the value of immunoscintigraphy with a monoclonal antibody (MoAb) against high molecular weight melanoma associated antigen (225.28S) was performed in 43 patients with choroidal melanoma; in six patients with a lesion suspected of being choroidal melanoma, and in seven patients with a benign lesion simulating a choroidal melanoma. The results of immunoscintigraphy in choroidal melanoma were compared with results of conventional diagnostic modalities like ultrasonography and fluorescein angiography. Planar scintigraphy showed a detection rate of 49% which is comparable with other studies. The detection with scintigraphy was correlated to the size of the choroidal melanoma. The use of single photon computed tomography did not increase the sensitivity of immunoscintigraphy. Ultrasonography yielded a correct diagnosis in 37 of 42 melanomas (88%). With fluorescein angiography a correct diagnosis was obtained in 11 of 30 melanomas (36.6%). The value of immunoscintigraphy with MoAb 225.28S in small choroidal melanomas is limited; its reliability increases in large tumours. Immunohistochemistry with MoAb 225.28S showed antigen expression in 95% of the stained tissue specimens of choroidal melanoma.
AuthorsD F Schaling, J A Oosterhuis, M J Jager, H Kakebeeke-Kemme, E K Pauwels
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 78 Issue 4 Pg. 244-8 (Apr 1994) ISSN: 0007-1161 [Print] England
PMID8199106 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm (analysis)
  • Choroid (diagnostic imaging)
  • Choroid Neoplasms (diagnostic imaging, ultrastructure)
  • Female
  • Fluorescein Angiography
  • Humans
  • Immunohistochemistry
  • Male
  • Melanoma (diagnostic imaging)
  • Middle Aged
  • Prospective Studies
  • Radioimmunodetection
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon (methods)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: